aluates Reports

$ 0.0

Automative

Global Breast Cancer Diagnostic and Drug Technologies Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-26D9461

Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2028

BUY CHAPTERS

Global Breast Cancer Diagnostic and Drug Technologies Market Insights, Forecast to 2030

Code: QYRE-Auto-26D9461

Report

December 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Roche

Biomerieux

Becton Dickinson

GE Healthcare

Hologic Inc

Philips

PerkinElmer Inc

Quest Diagnostics

Breast Cancer Diagnostic and Drug Technologies Market Size

The global Breast Cancer Diagnostic and Drug Technologies market is projected to grow from US$ 16930 million in 2024 to US$ 19060 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.

Breast Cancer Diagnostic and Drug Technologies Market

Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.

Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market

The US & Canada market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Breast Cancer Diagnostic and Drug Technologies include Abbott, Roche, BioMerieux, Becton Dickinson, GE Healthcare, Hologic, Philips, PerkinElmer and Quest Diagnostics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Breast Cancer Diagnostic and Drug Technologies is widely used in various fields, such as Ductal Carcinoma of Breast, Invasive Ductal Carcinoma, Lobular Carcinoma and Triple Negative Breast Cancer, etc. Ductal Carcinoma of Breast provides greatest supports to the Breast Cancer Diagnostic and Drug Technologies industry development. In 2023, global % revenue of Breast Cancer Diagnostic and Drug Technologies went into Ductal Carcinoma of Breast filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Breast Cancer Diagnostic and Drug Technologies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Breast Cancer Diagnostic and Drug Technologies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Breast Cancer Diagnostic and Drug Technologies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Breast Cancer Diagnostic and Drug Technologies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Breast Cancer Diagnostic and Drug Technologies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Breast Cancer Diagnostic and Drug Technologies revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Breast Cancer Diagnostic and Drug Technologies Market Report

Report Metric	Details
Report Name	Breast Cancer Diagnostic and Drug Technologies Market
Accounted market size in 2024	US$ 16930 million
Forecasted market size in 2030	US$ 19060 million
CAGR	2.0
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Mammography Biopsy Other
Segment by Application	Ductal Carcinoma of Breast Invasive Ductal Carcinoma Lobular Carcinoma Triple Negative Breast Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Roche, BioMerieux, Becton Dickinson, GE Healthcare, Hologic, Philips, PerkinElmer, Quest Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Breast Cancer Diagnostic and Drug Technologies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Diagnostic and Drug Technologies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast Cancer Diagnostic and Drug Technologies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Breast Cancer Diagnostic and Drug Technologies Market growing?

Ans: The Breast Cancer Diagnostic and Drug Technologies Market witnessing a CAGR of 2.0 during the forecast period 2025-2030.

What is the Breast Cancer Diagnostic and Drug Technologies Market size in 2030?

Ans: The Breast Cancer Diagnostic and Drug Technologies Market size in 2030 will be US$ 19060 million.

Who are the main players in the Breast Cancer Diagnostic and Drug Technologies Market report?

Ans: The main players in the Breast Cancer Diagnostic and Drug Technologies Market are Abbott, Roche, BioMerieux, Becton Dickinson, GE Healthcare, Hologic, Philips, PerkinElmer, Quest Diagnostics

What are the Application segmentation covered in the Breast Cancer Diagnostic and Drug Technologies Market report?

Ans: The Applications covered in the Breast Cancer Diagnostic and Drug Technologies Market report are Ductal Carcinoma of Breast, Invasive Ductal Carcinoma, Lobular Carcinoma, Triple Negative Breast Cancer

What are the Type segmentation covered in the Breast Cancer Diagnostic and Drug Technologies Market report?

Ans: The Types covered in the Breast Cancer Diagnostic and Drug Technologies Market report are Mammography, Biopsy, Other

Recommended Reports

Breast Cancer Markets

Cancer Diagnostics

Other Cancer Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Mammography

1.2.3 Biopsy

1.2.4 Other

1.3 Market by Application

1.3.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Ductal Carcinoma of Breast

1.3.3 Invasive Ductal Carcinoma

1.3.4 Lobular Carcinoma

1.3.5 Triple Negative Breast Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Perspective (2019-2030)

2.2 Global Breast Cancer Diagnostic and Drug Technologies Growth Trends by Region

2.2.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Region (2019-2024)

2.2.3 Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Region (2025-2030)

2.3 Breast Cancer Diagnostic and Drug Technologies Market Dynamics

2.3.1 Breast Cancer Diagnostic and Drug Technologies Industry Trends

2.3.2 Breast Cancer Diagnostic and Drug Technologies Market Drivers

2.3.3 Breast Cancer Diagnostic and Drug Technologies Market Challenges

2.3.4 Breast Cancer Diagnostic and Drug Technologies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Breast Cancer Diagnostic and Drug Technologies by Players

3.1.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2019-2024)

3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Players (2019-2024)

3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Breast Cancer Diagnostic and Drug Technologies, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio

3.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostic and Drug Technologies Revenue in 2023

3.5 Global Key Players of Breast Cancer Diagnostic and Drug Technologies Head office and Area Served

3.6 Global Key Players of Breast Cancer Diagnostic and Drug Technologies, Product and Application

3.7 Global Key Players of Breast Cancer Diagnostic and Drug Technologies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Type

4.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Type (2019-2024)

4.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2025-2030)

5 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Application

5.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Application (2019-2024)

5.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)

6.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type

6.2.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)

6.2.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030)

6.2.3 North America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

6.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application

6.3.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)

6.3.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030)

6.3.3 North America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

6.4 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country

6.4.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)

6.4.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)

7.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type

7.2.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)

7.2.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030)

7.2.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application

7.3.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)

7.3.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030)

7.3.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

7.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country

7.4.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)

7.4.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)

8.2 China Breast Cancer Diagnostic and Drug Technologies Market Size by Type

8.2.1 China Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)

8.2.2 China Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030)

8.2.3 China Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

8.3 China Breast Cancer Diagnostic and Drug Technologies Market Size by Application

8.3.1 China Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)

8.3.2 China Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030)

8.3.3 China Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)

9.2 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type

9.2.1 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)

9.2.2 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030)

9.2.3 Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

9.3 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application

9.3.1 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)

9.3.2 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030)

9.3.3 Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

9.4 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Region

9.4.1 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2019-2024)

9.4.3 Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type

10.2.1 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application

10.3.1 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country

10.4.1 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Introduction

11.1.4 Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.1.5 Abbott Recent Developments

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Introduction

11.2.4 Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.2.5 Roche Recent Developments

11.3 BioMerieux

11.3.1 BioMerieux Company Details

11.3.2 BioMerieux Business Overview

11.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Introduction

11.3.4 BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.3.5 BioMerieux Recent Developments

11.4 Becton Dickinson

11.4.1 Becton Dickinson Company Details

11.4.2 Becton Dickinson Business Overview

11.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Introduction

11.4.4 Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.4.5 Becton Dickinson Recent Developments

11.5 GE Healthcare

11.5.1 GE Healthcare Company Details

11.5.2 GE Healthcare Business Overview

11.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Introduction

11.5.4 GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.5.5 GE Healthcare Recent Developments

11.6 Hologic

11.6.1 Hologic Company Details

11.6.2 Hologic Business Overview

11.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Introduction

11.6.4 Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.6.5 Hologic Recent Developments

11.7 Philips

11.7.1 Philips Company Details

11.7.2 Philips Business Overview

11.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Introduction

11.7.4 Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.7.5 Philips Recent Developments

11.8 PerkinElmer

11.8.1 PerkinElmer Company Details

11.8.2 PerkinElmer Business Overview

11.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Introduction

11.8.4 PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.8.5 PerkinElmer Recent Developments

11.9 Quest Diagnostics

11.9.1 Quest Diagnostics Company Details

11.9.2 Quest Diagnostics Business Overview

11.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Introduction

11.9.4 Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

11.9.5 Quest Diagnostics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott

Roche

Biomerieux

Becton Dickinson

GE Healthcare

Hologic Inc

Philips

PerkinElmer Inc

Quest Diagnostics

List of Tables

Table 1. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Mammography

Table 3. Key Players of Biopsy

Table 4. Key Players of Other

Table 5. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Region (2019-2024)

Table 9. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Region (2025-2030)

Table 11. Breast Cancer Diagnostic and Drug Technologies Market Trends

Table 12. Breast Cancer Diagnostic and Drug Technologies Market Drivers

Table 13. Breast Cancer Diagnostic and Drug Technologies Market Challenges

Table 14. Breast Cancer Diagnostic and Drug Technologies Market Restraints

Table 15. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Players (2019-2024)

Table 17. Global Top Breast Cancer Diagnostic and Drug Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2023)

Table 18. Global Breast Cancer Diagnostic and Drug Technologies Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Breast Cancer Diagnostic and Drug Technologies, Headquarters and Area Served

Table 21. Global Key Players of Breast Cancer Diagnostic and Drug Technologies, Product and Application

Table 22. Global Key Players of Breast Cancer Diagnostic and Drug Technologies, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2019-2024)

Table 26. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2025-2030)

Table 28. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application (2019-2024)

Table 30. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application (2025-2030)

Table 32. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Breast Cancer Diagnostic and Drug Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Breast Cancer Diagnostic and Drug Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Breast Cancer Diagnostic and Drug Technologies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 64. Abbott Company Details

Table 65. Abbott Business Overview

Table 66. Abbott Breast Cancer Diagnostic and Drug Technologies Product

Table 67. Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 68. Abbott Recent Developments

Table 69. Roche Company Details

Table 70. Roche Business Overview

Table 71. Roche Breast Cancer Diagnostic and Drug Technologies Product

Table 72. Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 73. Roche Recent Developments

Table 74. BioMerieux Company Details

Table 75. BioMerieux Business Overview

Table 76. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product

Table 77. BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 78. BioMerieux Recent Developments

Table 79. Becton Dickinson Company Details

Table 80. Becton Dickinson Business Overview

Table 81. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product

Table 82. Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 83. Becton Dickinson Recent Developments

Table 84. GE Healthcare Company Details

Table 85. GE Healthcare Business Overview

Table 86. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product

Table 87. GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 88. GE Healthcare Recent Developments

Table 89. Hologic Company Details

Table 90. Hologic Business Overview

Table 91. Hologic Breast Cancer Diagnostic and Drug Technologies Product

Table 92. Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 93. Hologic Recent Developments

Table 94. Philips Company Details

Table 95. Philips Business Overview

Table 96. Philips Breast Cancer Diagnostic and Drug Technologies Product

Table 97. Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 98. Philips Recent Developments

Table 99. PerkinElmer Company Details

Table 100. PerkinElmer Business Overview

Table 101. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product

Table 102. PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 103. PerkinElmer Recent Developments

Table 104. Quest Diagnostics Company Details

Table 105. Quest Diagnostics Business Overview

Table 106. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product

Table 107. Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024) & (US$ Million)

Table 108. Quest Diagnostics Recent Developments

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Type: 2023 VS 2030

Figure 3. Mammography Features

Figure 4. Biopsy Features

Figure 5. Other Features

Figure 6. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2023 VS 2030

Figure 8. Ductal Carcinoma of Breast Case Studies

Figure 9. Invasive Ductal Carcinoma Case Studies

Figure 10. Lobular Carcinoma Case Studies

Figure 11. Triple Negative Breast Cancer Case Studies

Figure 12. Breast Cancer Diagnostic and Drug Technologies Report Years Considered

Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Breast Cancer Diagnostic and Drug Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Region: 2023 VS 2030

Figure 16. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players in 2023

Figure 17. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue in 2023

Figure 19. North America Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

Figure 21. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

Figure 22. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2019-2030)

Figure 23. United States Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

Figure 27. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

Figure 28. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2019-2030)

Figure 29. Germany Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

Figure 37. China Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

Figure 38. Asia Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

Figure 40. Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

Figure 41. Asia Breast Cancer Diagnostic and Drug Technologies Market Share by Region (2019-2030)

Figure 42. Japan Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2019-2030)

Figure 52. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Abbott Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 59. Roche Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 60. BioMerieux Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 61. Becton Dickinson Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 62. GE Healthcare Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 63. Hologic Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 64. Philips Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 65. PerkinElmer Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 66. Quest Diagnostics Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Breast Cancer Drugs Market Insights Forecast to 2030

Global Ovarian Cancer Diagnostics Technologies Market Insights Forecast to 2030

Global Breast Cancer Testing Market Insights Forecast to 2030

Global Breast Cancer Imaging Diagnostic Equipment Market Insights Forecast to 2030

Precision Cancer Diagnostic Tests Market

Breast Cancer Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Cancer Diagnostics Market

Global Breast Imaging Technology Market Insights Forecast to 2030

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Medical Imaging Technologies for Oncology Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Women s Health Diagnostics Market Insights Forecast to 2030

Global Uterine Cancer Therapies and Diagnostic Market Insights Forecast to 2030

Global Breast Cancer Targeted Drug Market Research Report 2025

Breast Cancer Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Noninvasive Cancer Diagnostics and Technology Market Research Report 2025

Global Breast Lesion Localization Market Insights Forecast to 2030

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Drug Discovery Technologies Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions